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In previous studies on the transplantable reticulum cell sarcoma (RCS) 1 of SjL/j 
mice, it was shown that normal T  lymphocytes from these mice gave high proliferative 
responses  to  syngeneic  "/-irradiated  RCS  cells  (1).  Incorporation  of antisera  to  Ia 
antigens of the SjL/j  strain  in the medium blocked the ability of the RCS cells to 
induce a proliferative response (2).  The responding cells were found to belong to the 
Lyt-1  subpopulation  of T  cells  from  lymph  nodes,  spleen,  and  thymus  of normal 
syngeneic SJL/J mice (3). 
Lymph node (LN) cells from recombinant strains A.TH and A.TL were also tested 
for responses to RCS, and it was noted that A.TL LN cells responded much less than 
A.TH, whereas A.SW and BIO.S gave good responses (2).  This suggested a  require- 
ment for a similar I region in responder and stimulator cells. It was further observed 
that the F1 hybrids ofSJL ×  A.SW and SJL ×  C57BL/6 responded with proliferation 
(1,  4),  whereas  F1  hybrids  of SJL  ×  BALB/c  did  not,  which  perhaps  suggests  a 
negative influence from the BALB/c parent  (4).  Therefore, to evaluate in detail the 
genetic requirements in  responding cells, an extended  series of F× hybrids of SJL/J 
mice  with  a  variety  of other  strains,  differing  in  H-2  subregions  and  on  various 
backgrounds, were examined for the ability to give a  proliferative response in vitro. 
It was also noted previously that the readily transplantable  RCS tumor failed to 
grow in syngeneic hosts, if the latter had been irradiated before tumor cell injection 
(5).  Because normal LN cells were shown to enhance growth of subsequently injected 
tumor cells in  irradiated  mice, it was suggested that  proliferation of normal T  cells 
was needed for growth (5). In these studies, therefore, the ability of FI hybrids of SJL/ 
* Supported by grants CA-14462, CA-16247, and CA-22544 from the National Cancer Institute, U. S. 
Public Health Service, and AI-12734 from  the National Institutes of Health. 
i Abbrevzations used in t&s paper: Con A, concanavalin A; LN, lymph node(s); NK, natural killer; PEG, 
polyethylene glycol; PHA, phytohemagglutinin; RCS, reticulum cell sarcoma(s). 
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TABLE  I 
H-2 Haplotype Subregions of Parental Strains  Used to Make F1 Hybrids with sjL 
Strain  K  IA  IB  IJ  IE  IC  S  G  D 
SJL/J  s  s  s  s  s  s  s  s  s 
A.SW  s  s  s  s  s  s  s  s  s 
A.TH  s  s  s  s  s  s  s  s  d 
A.TL  s  k  k  k  k  k  k  k  d 
A.AL  k  k  k  k  k  k  k  k  d 
A/J  k  k  k  k  k  d  d  d  d 
A.CA  f  f  f  f  f  f  f  f  f 
ATFR.4  f  f  ?  ?  ?  ?  s  s  d 
ATFR.5  f  f  f  f  k  k  k  k  d 
BI0.S  s  s  s  s  s  s  s  s  s 
8R  k  k  )  ?  s  s  s  s  s 
7R  s  s  s  s  s  s  s  s  d 
BI0.HTT  s  s  s  s  k  k  k  k  d 
9R  s  s  ?  k  k  d  d  d  d 
BI0.A  k  k  k  k  k  d  d  d  d 
BI0.A(5R)  b  b  b  k  k  d  d  d  d 
BI0.HTG  d  d  d  d  d  d  d  ?  b 
BI0.D2  d  d  d  d  d  d  d  d  d 
BI0  b  b  b  b  b  b  b  b  b 
BALB.K  k  k  k  k  k  k  k  k  k 
BALB/c  d  d  d  d  d  d  d  d  d 
BALB.B  b  b  b  b  b  b  b  b  b 
B6  b  b  b  b  b  b  b  b  b 
DBA/2  d  d  d  d  d  d  d  d  d 
D2.GD  d  d  b  b  b  b  b  b  b 
j  mice  to  support  RCS  growth  was  examined  in  parallel  with  the  proliferative 
responsiveness  of their LN  cells to y-irradiated  RCS  cells. It will be shown  that  various 
subregions  of H-2 k and  H-2 a  haplotypes  have  strongly  negative  influences  on  both  of 
these parameters,  whereas  H-2 f and  H-2 b parental  haplotypes  have  less or no influence 
on  permissiveness  for  RCS  growth  and  on  proliferative  responsiveness  of T  cells  to 
RCS  in  F1  hybrids  of SJL/J  mice. 
Materials  and  Methods 
Mice and Tumors.  SjL/j  mice were  purchased from The Jackson  Laboratory  (Bar Harbor, 
Maine).  All F1  hybrid  mice were bred  in our animal  facilities. The  strains used and  their H-2 
locus subregions have been  outlined  in  Table  I.  The  RCS-5  and  RCS-19  tumors originated 
from  spontaneous  RCS  in  SJL/J  mice  and  were  transformed  into  transplantable  lines  by 
Carswell  et  al.  (6,  7);  transplantable  RCS-X  was derived  from a  primary  tumor  of an SjL/j 
mouse  in  our  laboratory.  RCS-5  and  RCS-X  have  been  maintained  by  serial  intravenous 
passage of ~  107 tumor-infiltrated LN cells into syngeneic young mice, at weekly intervals. RCS- 
19 has been passaged intraperitoneally  at  10  v cells.  For determination  of growth in F1  hybrids 
RCS-5 or RCS-X  LN tumor cells were injected intravenously, 7 d  after passage, at  10  v cells per 
mouse, into groups of five mice. Because growth of RCS  tumor occurs primarily in peripheral 
lymphoid organs, weights of spleen and mesenteric, brachial, and axillary LN, determined  7 d 
after  injection  and  expressed  as  percentage  of body  weight,  were  used  as  indices  of tumor 
growth, y-Irradiated  tumor cells (10,000 y-RCS) were used to control for apparent  growth, i.e., 
LN  and  spleen weight  increases as  a  result  of the proliferative  response  to  RCS  in  vivo  (4). 
Therefore, in each experiment an additional group of three mice were injected with  I0  T y-RCS, 
and  the  percentages  of LN  and  spleen  weights  in  terms of body  weight  in  these  mice  were KATZ, LERMAN, PONZIO,  SHREFFLER,  AND THORBECKE  349 
subtracted from those obtained in mice injected with unirradiated RCS. Thus, the following 
formula was used to express growth in Fl hybrids as percentage of growth in SjL/j mice: 
Percent growth 
(index in F1 hybrid with live RCS) -  (index in FI hybrid with y-RCS) 
=  x  100. 
(index in SJL/J with live RCS) -  (index in SjL/j with ~,-RCS) 
Overall control values for  14 experiments with viable RCS cells in groups of 5 9 SJL/J mice 
gave indices of 3.604 _+ 0.146 for LN and 4.090 _  0.208 for spleen. The indices in 9 mice with 
y-irradiated  RCS  cells  were  0.758  -  0.032  for  LN  and  1.095  +  0.057  for  spleen  (eight 
experiments with three mice each).  Control values for viable RCS cells in d  mice were 2.347 
+  0.114 for LN and 3.960 +  0.091 for spleen in six experiments with groups of five mice each, 
and for y-irradiated RCS in d~ mice in three experiments: 0.552  +  0.053  for LN and  1.009 _+ 
0.145 for spleen. These results showed better growth in 9 than in ~ SjL/j mice. Separate control 
values for ~ and d  SJL/J  mice were,  therefore, applied in the determination of growth in F1 
hybrid 2 and c~ mice. 
Cell Cultures 
RESPONSES TO  RCS.  Lymphocyte  cultures  from  single cell  suspensions prepared  from 
mesenteric, brachial, and axillary LN, were set up on flat-bottom Linbro tissue culture plates 
(No.  76-003-05, Linbro Chemical Co.,  Hamden, Conn.) in RPMI-1640 (Associated  Biomedic 
Systems,  Inc., Buffalo,  N. Y.) with  10% fetal calf serum (Grand Island Biological  Co., Grand 
Island, N.  Y.)  and 5 X  10  -s M  2-mercaptoethanol (Eastman Kodak Co.,  Rochester, N.  Y.). 
Cells used for stimulation of a proliferative response were y-irradiated RCS cells (6,000 R, 137Cs 
source,  Radiation Machinery Corp., Parsippany, N. J.).  Responder cells were used at 2 ×  10  s 
cells/well, (106 cells/ml), whereas irradiated RCS stimulator cells were used at 5 ×  104 cells/ 
well. In all experiments nonspecific stimuli were used as a measure of lymphocyte reactivity. 
These included a  72-h incubation with concanavalin A  (Con A 5 #g/ml: Miles-Yeda, Miles 
Laboratories  Inc.,  Elkhart,  Ind.)  and  phytohemagglutinin (PHA)  (PHA-P,  5 /xg/ml;  Difco 
Laboratories, Detroit,  Mich.).  Results of RCS stimulation were considered valid only when 
Con A and PHA induced appropriate stimulation. Thymidine incorporation (as counts per 
minute) into cell DNA was measured in five replicate cultures.  1 btCi of [aH]thymidine, (0.36 
Ci/mmol, Schwartz/Mann Div., Becton, Dickinson & Co.,  Orangeburg, N.  Y.) was added to 
each well on day 3 of culture. On day 4, the cultures were collected on glass fiber filter disks 
(H.  Reeve Angel & Co.,  Inc., Clifton, N. J.)  with an automated cell harvester. Radioactivity 
was measured in a Packard tricarb scintillation  counter (Packard Instrument Co., Inc., Downers 
Grove, Ill.), using Scintiverse (Fisher Scientific Co., Pittsburgh, Pa.) liquid scintillator cocktail. 
Proliferative responses to RCS were expressed  as increases in counts per minute over the counts 
per minute in control cells cultured in the absence of stimulation. Responses of LN cells from 
F1 hybrid mice were  expressed  as percentages of the response obtained with SJL/J  LN cells 
cultured simultaneously and stimulated with the same y-RCS preparation: 
Percent proliferative response 
_- (FI hybrid +  y-RCS mixed) cpm -  (F~ hybrid cpm +  y-RCS cpm) 
×  100. 
(SJL/J +  y-RCS mixed) cpm -  (SJL/j cpm + y-RCS cpm) 
Results were expressed  as means +  standard errors (n). 
MIXED  LYMPHOCYTE CULTURES WITH NORMAL SYNGENEIC STIMULATOR CELLS.  Stimulator cells 
in these cultures were  treated with mitomycin C  (Drug Synthesis Branch Division of Cancer 
Treatment, National Cancer Institute, Bethesda, Md.). To enhance the response of LN cells to 
mitomycin-treated syngeneic spleen cells, 4% (wt/vol) polyethylene glycol (PEG), 6,000 mol wt 
(Sigma Chemical Co., St. Louis, Mo.), was added to the culture medium (8). 2 X 105 F1 hybrid 
nylon wool  (9)  nonadherent LN cells  were  used as  responder cells  and were cultured with 
mitomycin-treated (25 #g/ml, 45 rain at  37°C) syngeneic, parental, or allogeneic spleen cells 
(2 X l0  p) or with mitomycin-treated (60/~g/ml, 45 min at 37°C) RCS cells (4 X 104) in medium 
that contained 4% PEG. Cultures were pulsed with 1/~Ci [aH]thymidine 16 h before harvest at 
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TABLE II 
Decrease of RCS Growth and of Proliferative Responsiveness to RCS In  Vitro under the Influence of H-2 
Haplotype Subregions and Non-H-2 Genes in F1 Hybrids of SjL/j Mice 
Back-  H-2 haplotype subregions 
Strains compared  ground  involved 
Negative effect on* 
Growth  Proliferative response (P) 
A.SW vs.  SJL/J  A  Non H-2: A  vs, SJL  +++  +++ 
ACA vs.  A,SW  H-2:  fvs.  s  +  ++ 
A.TH  vs. A.SW  D-end:  d  vs. s  (A)  ++  0 
A.TFR4  vs. ACA  D-end:  d  vs.  f  (A)  ++  0 
A.TL  vs. A.TH  LG:  k vs. s  +++  +++  (0.001  <  P<  0.01) 
A.TFR5  vs. A.TFR4  I-E-G: k  vs.  for s  +++  ++  (0.01  <  P  <  0.02):~ 
A.AL vs  A.TL  K-end: k  vs.  s  0?§  +?§ 
BI0.S vs. SjL/j  B[0  Non  H-2:B10  vs. SJL  +++  ++ 
BI0 vs.  BI0.S  H-2: b  vs. s  0  0 
BI0.D2 vs. BI0.S  H-2: d  vs. s  ++++  ++++ 
B10.S  (TR) vs.  B10.S  D-end:  d  vs s  ++++  +++  (0.1  <  P<  0.2) 
BI0.D2 vs  BI0.HTG  D-end:  d  vs.  b  ++§  0§ 
BI0.HTr  vs. 9R  I-B-I-J: k  vs. s  0  0 
(BI0.HTT;  9R)  vs.  7R  I-E/C:  k or d  vs. s  +§  ++  (0.02 <  P<  0.05) 
[BI0.A(5R); BI0.A]  vs.  (BI0.HTT;  9R)  K  +  I-A-I-J: b  or k vs, s  ?§  ++  (0.001  <  P<: 0.01) 
B10.A vs.  9R  K  +  I-A-I-B: k  vs. s  ?§  ++§ 
BI0.A(5R)  vs. 9R  K  +  1-A-I-B: b  vs. s  ?§  ++§ 
BI0 S(SR) vs. BI0.S  K  +  l-A-I-J: k  vs. s  +++  +++  (0.05 <  P<  0.1) 
BI0.HTG  vs. BI0  K  +  I-G: d  vs.  b  +++  ++++  (P<  0.001) 
BALB.B vs.  BI0  BALB  Non  H-2:  ~)  + 
BALB.K vs.  BALI~.B  H-2: k  vs. b  ++++  ++++ 
BALB/c  vs.  BALB.B  H-2: d  vs.  b  ++++  ++++  (0.01  <  P<  0.02) 
DBA/2  vs.  D2.GD  DBA/2  D-end +  I-B-G: d  vs. b  +++  +++ 
* A  decrease of 1-10% was considered +; of 11-30'7,  ++;  of 31  50% +++,  and of >50'7~,  ++++. 
This significance  determination was made taking A.TFR4  +  A.CA  together  vs.  A.TFR5,  because the D  end did not appear to affect the 
proliferative response. 
§ Minimal estimate or no value given, because growth and/or proliferative response had reached lowest measurable values. 
Results 
Growth  of RCS in  Various F1 Hybrids.  An examination was made of the abilities  of 
various  Fa  mice  to  support  growth  of  107  RCS  cells  injected  intravenously.  Fig.  1 
shows the results obtained in F1 hybrids of SjL/J with a number of recombinant mice 
of A-strain background. It can be seen that SJL X A.SW mice had the highest tumor 
growth  in  this  series,  which  was  still  less  than  the  growth  seen  in  SJL/J  mice 
themselves  (49.7  _+ 6.1% for LN and 86.5  +  9.8% for spleen).  These results indicate 
that the A background had a dominant negative effect on tumor growth, particularly 
in  the LN.  Growth was further  reduced  by ~20-30%  in  the  F1  hybrid with A.TH, 
which  suggests  a  significant  but  not  very  large  negative  effect  of the  H-2D  d end. 
Changing from A.TH to A.TL, as the other Fa hybrid parent, caused a complete loss 
of growth, which indicates a strongly negative effect of I  k. In view of the fact that F1 
hybrids with A.TL did not show any significant  tumor growth, any further negative 
effect of H-2K  k could not be analyzed (Table II). 
A  comparison between  the F1 mice with A.SW and with A.CA showed that  H-2 f 
allowed almost as much tumor growth as did H-2  ~, and certainly much more than H- 
2  k. Comparing A.TFR4 with A.CA again showed a negative effect of the H-2D  d end 
of ~20-30%. Of particular interest was the comparison between A.TFR4 and A.TFR5 
because all growth was lost by a change in regions I-E/C, -S, and -G from H-2 fs to H- 
2  k" 
Fig.  2 shows the results obtained with F1 hybrids of SJL by BIO background mice. 
Like  the  A  background  the  BIO  background  also  introduced  a  highly  significant KATZ, LERMAN, PONZIO, SHREFFLER, AND THORBECKE  351 
decrease  in  growth  in  the  LN  (57.8  _+  12.0%)  with  somewhat  less  effect on  spleen 
growth  (64.5  +  9.0%).  Growth in F1  hybrids with  BIO was at least as good as in Fa 
hybrids with BIO.S. Thus, H-2  b was as permissive for tumor growth as was H-2  s itself. 
The left-hand region of H-2  k had a  negative effect of 25-35%  (compare BIO.S and 
BIO.8R), but not as strong as the H-2D  d end, which almost abolished  RCS growth 
[Table II, BIO.S(7R) vs. BIO.S]. When H-2  d was present in every region except in the 
H-2D end it caused a 40-50% decrease in growth (Table II, BIO.HTG vs. BIO). The 
effect  of the  I  subregion  could  not  be judged  very well  on  the  BIO  background 
because  of the  strongly  negative effect of H-2D  d,  but  the  5-9%  decrease  (minimal 
estimate) between BIO.S(7R) and BIO.HTT or BIO.S(9R) suggested a negative effect 
of the combined I-E/C, -S, and -G regions. 
Fig. 3 shows the results obtained with mice of B6, BALB, and DBA2 backgrounds. 
The permissiveness of H-2  b as compared with H-2  d or H-2  k was again brought out by 
examination of F1 hybrids with B6 and BALB.B mice. Both of these F1 hybrids were 
very similar to those of BIO.S and BIO, whereas growth in F1 hybrids of BALB/c (H- 
2  d)  or BALB.K (H-2  k) was totally lacking. Of all backgrounds examined with H-2  b, 
the  BALB  background  appeared  the  most  permissive for RCS  growth.  A  strongly 
negative effect of the presence of H-2  d in regions to the right of I-A was again deduced 
from the comparison of D2.GD and DBA/2 F1 hybrids with SJL (Table II). 
Various Parameters of RCS  Growth  in  171  Hybrids.  The  effect  of  time  after  RCS 
injection was further examined in some permissive as well as nonpermissive FI hybrids. 
SJL/J mice usually die before the  10th d after injection of 10  7 RCS cells, but most of 
the Fl  hybrids survived at  least until  day  14.  The results in Table III (expressed as 
percentage of growth  in  SjL/j  ×  A.SW)  show that  growth  was progressive during 
that time both in permissive F1 hybrids (such as SJL ×  A.SW and SJL ×  A.TH) and 
in relatively nonpermissive F1 hybrids (such as SJL ×  7R), whereas the least-permissive 
F1 hybrids (such as SJL ×  BALB/c and SJL ×  A.TL) actually showed regression of 
the  tumor with  smaller spleen  sizes at  14  than  at  7 d  after RCS  injection.  Larger 
tumor  cell  doses  (5  ×  107) did  not  increase  tumor  growth  in  the  least-permissive 
strains.  10-fold lower RCS doses (106 cells) grew as well in permissive strains (SJL × 
B6)  as did  the  usual  dose of 107  (Table IV).  Injections of  104  RCS  cells,  although 
causing at least temporary growth in SJL mice, did not result in detectable growth, 
even in SJL ×  B6 (data not shown). 
Although by far the majority of experiments were carried out with the tumor line 
RCS-5, a comparison was made with RCS-X and RCS-19 in a permissive (SJL ×  B6) 
and in a  nonpermissive strain  (SJL ×  BALB/c). The results in Table IV show that 
the three RCS lines all grew well in the F1 of B6, whereas none of the lines grew in the 
F1 of BALB/c. Previous studies on induction ofT-cell cytotoxicity and on proliferative 
responses to y-RCS (1, 4) have also failed to detect differences between these separate 
transplantable lines. 
It should also be noted that SJL/J by other parent invariably gave identical RCS 
growth, as did the reciprocal F1 hybrids, (data not shown). 
Effect  on RCS Growth of Whole Body y-Irradiation  of the Host before RCS Injection.  F1 
hybrid mice that were relatively permissive for RCS growth showed a similar inability 
to grow the tumor when they were irradiated before RCS injection, as was previously 
described for SJL/J mice themselves (5,  10). In a series of experiments with SJL ×  B6 
mice, for instance,  mice that  had been irradiated  with 650  R  1 d  before tumor cell 352  RETICULUM  CELL  SARCOMA  IN  SJL/J  F]  HYBRIDS 
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Fit;.  1-3.  Tumor growth in each experiment was expressed as the percentage of growth in control 
groups of five SJL/J  mice,  and  corrected  for  the  in  vivo proliferative response  as  indicated  in 
Materials and Methods by use of y-irradiated RCS cells. Each value represents the mean of two to 
five experiments.  Bars  indicate the  standard  errors  for  those  F~  hybrids where  more  than  two 
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TABLE  III 
Effect of RCS Cell Dose and Time after Injection  on Growth  in F1 Hybrids 
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Time after  Number of  Strain  injection  RCS cells 
(Organ/body weight)  Percent growth in 
X  100  SJL x  ASW 
LN  Spleen  LN  Spleen 
SJL X A.SW  1 wk  10  7  1.57"  3.54  100  100 
5 X  107:[:  3.08  3.51  100  100 
2 wk  l0  v  2.41  5.01  100  100 
SJL x  SJL  1 wk  107  3.56§  4_14  226  117 
5 x  107~  4.28  3.29  138  93 
SJL x  A.TH  1 wk  10  7  1.13"  2.54  72  72 
5 X  10  7  2.54  4.43  82  126 
2 wk  107~  2.80  4.33  116  86 
SJL X 7R  1 wk  107  0.6311  1.07  19  30 
5  X  10 7  0.73  1.30  24  37 
2 wk  10 7  1.61  2.62  67  52 
SJL X A.TL  l  wk  107  0.53tl  1.07  34  30 
5 ×  107  0.70  1.04  23  30 
2 wk  107  0.76  0.67  32  13 
SoIL X BALB/c  1 wk  107  0.58  0.97  37  27 
5 ×  107  0.75  1.86  24  53 
2 wk  107  0.52  0.89  22  18 
5 x  107  0.46  0.70 
* Mean of six experiments. 
:1: Grossly enlarged livers at time of death. 
§ Mean of 15 experiments; no survivors at 2 wk. 
[1 Mean of three experiments; 5 mice/group in each experiment. 
TABLE  IV 
Growth * of Three Different Transplantable  RCS in SJL/J Mice and F1 Hybrids 
Time after  Tumor  Strain 
injection  dose:~  SjL/J x 
RCS-X  RCS-5  RCS- 19 
LN  Spleen  LN  Spleen  LN  Spleen 
1 wk  107  SJL  100%  100%  100%  100%  100%  100% 
(2.89)*  (2.66)  (2.11)  (2.05)  (0.49)  (2.63) 
B6  41%§  48%  48%  84%  ND[]  83% 
BALB/c  <1%  3%  <1%  4%  ND  3% 
1 wk  106  SJL  100%  100%  100%  100%  ND  ND 
(1.31)  (1.28)  (0.88)  (0.82) 
B6  43%  40%  41%  74%  ND  ND 
2 wk  106  SJL  100%  100%  100%  100%  100%  100% 
(5.32)  (3.99)  (4.88)  (4.30)  (0.63)  (3.24) 
B6  65%  98%  69%  123%  ND  !03% 
10 7  BALB/c  <1%  <1%  ND  ND  ND  <1% 
* Growth  was  expressed as  (organ/body  weight)  ×  100  after  injection  of live  tumor  from  which  was 
subtracted the value for (organ/body weight) ×  100 after injection of X-irradiated  (10,000 R)  tumor. 5 
mice/group in each experiment. 
:~ Tumor cells were injected intravenously. 
§ Expressed as percentages of values obtained in SJL/J mice with the same RCS cells. 
II LN values not determined for RCS-19 because growth in LN even in the SJL/J mice was poor with this 
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Proliferative responses in F1 LN cells are expressed as percentage of the response in SJL/J 
to the same preparation of y-irradiated RCS cells. LN cells pooled from two mice (brachial, 
axillary, and mesenteric LN) were used in each experiment. Each value represents the mean of the 
indicated number (n) of experiments (given on top of bar). Bars indicate standard errors for more 
than two experiments, and extreme values where only two experiments are included. 
injection showed spleen sizes that were only 33-42% of those in unirradiated mice  1 
wk after RCS  injection. Comparable experiments  in  SJL  mice showed  a  somewhat 
greater reduction in growth, to 26% of the unirradiated SJL mice (data not shown). 
Further  Examination  of the  H-2Dd-End  Effect.  Measures  to  counteract  an  effect 
mediated  by the  Hh  genes  of classical F1  hybrid resistance  (11)  include treatment 
with  silica (12,  13),  carrageenan  (14,  15),  or cyclophosphamide  (16).  In  a  previous 
study  (17)  all these  M  cell-inhibiting agents were  shown  to  inhibit  RCS  growth  in 
SJL  mice  (5),  which  was  interpreted  as  showing  a  helping effect  of cells with  the 
properties of M  cells on  RCS  growth.  It  was  therefore  not  surprising  to  find  that 
pretreatment with 3 mg silica i.v. in F1 hybrids of SJL by A.TFR4, 7R, or A.TH mice 
did not enhance RCS growth (data not shown). 
The only measure, which is also known to overcome the F1 hybrid resistance linked 
to the D  end and which could be studied here, was that of increasing the tumor dose. 
The results in Table III with 5  X  107 instead of the usual  107 RCS cells showed that 
the negative effect of the D  end in A.TH was significantly reduced. At this high tumor 
dose,  the  I-region effect shown  by  the comparison  between  F1  hybrids of SJL  with 
A.TH  and  A.TL  was  much  greater  than  it  was  with  the  usual  dose,  whereas  the 
difference between A.SW and A.TH was minimal. 
Ability of LN Cells From Various Fa Hybrids to Give a Proliferative Response to RCS.  It 
was previously found that T  cells from certain Fa hybrids of SjL/j  mice did not give 
as good a  proliferative response to 3,-irradiated RCS as did T  cells from SJL/J  mice 
(1, 4). The results presented in Fig. 4  show relative abilities to give this proliferative 
responsiveness for all the SJL/J F1 hybrids examined. 
In general, the ability to give this proliferative response varied in a  manner similar 
to  the  ability of the  F1  hybrids  to  grow  the  tumor  (Table  II).  The  most  obvious 
exception to this apparent rule was the lack of effect of the H-2D  d end on proliferation 
in F] hybrids with A  background, which contrasted with a  -20%  effect of this locus 
on  growth.  There was  a  negative effect of the H-2D  a end on  proliferation in  the Fa KATZ, LERMAN,  PONZIO, SHREFFLER, AND THORBECKE  355 
hybrids with  BIO background,  but  this  effect  was  more variable  and  less  marked 
than the H-2Da-end effect on growth (Table II). Because the change of the H-2D end 
to H-2  a did not completely abolish the proliferative responsiveness, the effect of the I 
region on the proliferative responses could be measured, whereas its effect on tumor 
growth  could  not.  Both  the  A  and  the  BIO  backgrounds  caused  a  decrease  in 
proliferative responsiveness, but the effect of the A background was much greater. 
It was evident that the I region, both the I-A and I-E/C loci, had a strong effect on 
the proliferative responsiveness to RCS regardless of genetic backgrounds. Particularly 
interesting  was  the  observation  that  H-2  b and  H-2  f caused  a  loss  of proliferation, 
which appeared as a  result  of the I-A +  K  regions  (Fig.  4;  Table II), whereas  H-2  k 
and  H-2  d caused negative effects in  both the I-A and  I-E/C regions.  Moreover the 
effects of the I-A and I-E/C regions appeared additive in the sense that SJL X A.TH 
and  SJL  X  A.TL  (I  s vs.  I  k)  differed  by 40%,  whereas  SJL  X  A.TFR4 and  SJL  X 
A.TFR5  (I-E/C  f or _s vs. I-E/C  k)  differed by only 20%.  Similarly, SJL X BIO.HTT 
or 9R were 15-16% below SJL X  7R (I-E/C  k or _d vs. I-E/CS), whereas in turn, they 
were  11-18% above SJL X BIO.A or BIO.A(5R) (K  k +  I-A  k or K b +  I-A  b vs. K s +  I- 
A s)  in ability to proliferate (Fig.  4; Table II). 
Comparison of BIO.S(8R) and BIO.S indicated, however, that the negative effect 
of K k +  I-A  k in BIO.A was likely to be an underestimation, because the effect of these 
same regions was much greater (42%) when regions to the right of I were all s. This 
also indicated that H-2  k in K  +  I-A had a  larger negative effect than did H-2  b or H- 
2  f, which  even  as  the  complete H-2 regions  had  barely detectable  negative effects. 
Even without the H-2D  a end, H-2  a in K, I, S, and G  alone, had a  strongly negative 
effect on both proliferation and growth (Fig.  4; Table II, BIO.HTG vs. BIO). There 
was no apparent difference between F1 hybrids with BIO.HTT and BIO.(9R), which 
indicates that the I-J region was relatively unimportant in this phenomenon and that 
a change in the I-C region from k to d had no effect. 
Comparison Between Responses ofF1  T Cells to Syngeneic Parental and RCS Cells.  If the 
response to y-RCS were an exaggerated form of the syngeneic MLR, a corresponding 
variability among F1 hybrids in  their  responsiveness  to  normal  SJL cells  could  be 
expected.  It  seemed  important,  therefore,  to  determine  whether  F~  hybrid T  cells 
could give equally high responses to parental as to syngeneic mitomycin-treated spleen 
cells. 
These responses were all determined in medium that contained PEG because the 
presence of this agent enhances responses (8).  The results in Table V  show that the 
responses to normal non-T cells of syngeneic and parental origin were approximately 
equally high for each of the F1 hybrids studied. In contrast, the response to RCS was 
higher in those strains that also had good responses to RCS without PEG, i.e.,  SJL 
X  8R  and  SJL  X  A.TH.  In  the  strains  that  had  low to  absent  responses  to  RCS 
without PEG, proliferation to normal SJL spleen and tumor cells  was equally high, 
i.e., SJL ×  A.TL and SJL X A/J (Table V). Similarly, the responsiveness of thymus 
cells  to  RCS  as  compared with  SJL spleen  cells  was  100-  to  200-fold higher  in  Fa 
hybrids  with  haplotypes  that  contained  I-A-C  ~ or  -f,  or  even  I-E/C  s  alone  (8R), 
whereas  it  was only two-  to  threefold  higher in  the  ones  with  I-A-C  k or d.  These 
findings suggest that those strains that give high responses to RCS recognize something 
additional on RCS that is not expressed on normal SJL/J cells and that they recognize 
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TABLE V 
Proliferation Induced in SJL F1 Hybrid LN T Cells by Syngeneic and Parental Stimulator Cells 
F1 hybrid  Responder* cells 
responder LN  alone 
A cpm:~ after stimulation with 
SJL parental  Syngeneic FI  Non-SJL paren-  RCS 
spleen  spleen  tal spleen 
cpm 
SJL x A.TH  743  46,736  40,102  38,915  189,348 
(1.0)  (0.9)  (0.8)  (4.1) 
SJL × A.TL  4,158  101,655  47,648  84,800  102,644 
(1.0)  (0.5)  (0.8)  (t.0) 
SJL x A/J  7,684  47,082  47,373  52,704  36,481 
(1.0)  (1.0)  (1.1)  (0.8) 
SJL x 8R  121  47,665  86,024  60,245  227,777 
(i.0)  (1.8)  (1.3)  (4.8) 
SJL x  7R  231  71,057  66,794  79,502  99,232 
(1.0)  (0.9)  (1.1)  (1.4) 
* Responder cells (2 ×  105) were nylon wool nonadherent  LN cells; stimulator cells (2 ×  10  ~ for spleen and 
4 ×  104 for RCS) were mitomycin treated (Materials and Methods). The medium  for all these cultures 
contained 4% PEG. 
:~ A cpm = cpm in cell mixture from which was subtracted the sum ofcpm in seperately cultured FI hybrid 
LN and mitomycin-treated  spleen or RCS cells. Numbers in parentheses below A cpm reflect relative 
degree of stimulation as compared with responses to normal SJL/J cells. 
Discussion 
The results indicate a  variety of genetic influences in F1 hybrids of SJL/J, both on 
the ability to support RCS growth and on the proliferative responsiveness of LN cells 
to  y-RCS.  In  the  first place there  is an  effect of background,  non-H-2,  genes  in  A, 
BIO, B6, and less in BALB F1 hybrids that decreases growth. The negative effect of 
non-H-2  genes on  proliferative responses is most  evident with A  and  B6,  and  is less 
marked with BALB and BIO backgrounds. The mechanism of this effect has not been 
examined further.  Examples in the literature of non-H-2 influences on tumor induc- 
tion in F1 hybrids have frequently been related to genes controlling permissiveness to 
murine  leukemia virus  infections  (18-20),  but  little is  known  about  the  possibility 
that RCS is caused by such a  virus in SJL/J mice (21, 22). Previous studies have not 
suggested the presence of murine leukemia virus antigens in transplantable RCS lines 
(2). In a recent study, Walker and Phillips-Quagliata (23, 24) have described a strong 
non-H-2  effect  on  growth  of  BALB/c  plasmacytomas  in  F1  hybrid  mice,  which 
suggests that it might be related to the expression of viral antigens on the tumor cells. 
Classical  F1  hybrid  resistance,  as  described by  Cudkowicz  and  Bennett  (11,  17), 
relates  to  the  inability of parental  H-2 b  bone  marrow  transplants  to  grow  in  F1 
hybrids, but  also applies to growth of certain  lymphomas of H-2 k or H-2  b parental 
origin  (25-28).  Previous  studies  of Warner  (29)  have  shown  that  such  F1  hybrid 
resistance to SjL/j  bone marrow and myeloid leukemia is also shown  by F1 hybrids 
of SJL/J with strains carrying H-2 k or H-2  a, but much less in F1 with H-2 b. Thus,  F1 
hybrid resistance directed against homozygous H-2 S cells similar to the one observed 
here has been described before. Although originally this type of resistance, regulated 
or controlled by Hh genes, was thought to map to the right of H-2D, in recent studies 
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of cytotoxicity in vitro, the resistance was mapped to antigens specified by H-2D  b and 
H-2K  k (31,  32).  Although some of the background effect may be a  result of similar 
Hh genes, the clear effect of H-2D  d, and not of H-2D  b, in the F~ hybrids examined in 
our studies,  suggests an  Hh gene-effect that  results  in resistance to  H-2  ~, controlled 
either by H-2D itself or by a  locus adjacent to it. Our data do not exclude a similar 
effect in the H-2K end, particularly in H-2Kk-carrying F1 hybrids. 
Natural  killer  (NK)  cells have recently been suggested as the prime mediators of 
this form of F1 hybrid resistance in  vivo (33-36).  Presumably the effect of H-2D  d is 
less marked on the A than on the BIO background, as shown in our studies, because 
the A strain has less NK activity (37).  The effect of high tumor cell dosage, partly (on 
BIO background)  or completely (on A  background)  overriding the H-2Dd-mediated 
resistance,  is  in  agreement with  observations in  the  literature  concerning  Hh  gene- 
mediated FI hybrid resistance (11).  The peculiar behavior of RCS in irradiated SJL/ 
J  mice, in which it does not grow, and in which its growth is facilitated by a  cell (or 
more than one cell type), which is sensitive to silica, carrageenan, and trypan blue (5) 
precludes a  detailed analysis of the effect of these agents on the F1 hybrid resistance. 
Growth of SJL RCS in the permissive F1 hybrids is also inhibited by these agents and 
by irradiation of the host before tumor cell injection, as it is in SJL/J mice themselves 
(5). 
It  is  of interest  that  Nakamura  and  Cudkowicz  (38)  found  a  need  for  "back- 
stimulation" of F1 responders by irradiated T  cells in the parental stimulator cells for 
the induction of a cytotoxic response of F1 anti-parent. It seems likely that the ability 
of RCS to induce proliferation in Fa cells would enhance the F1 hybrid resistance to 
RCS  growth, but,  actually a  positive correlation  between  growth  and  proliferation 
was usually seen rather than an inverse correlation. For similar reasons, it is of interest 
to mention here that RCS was recently observed to produce immune type II interferon 
(39).  In view of the activating effect of interferon on NK activity (40)  this property 
would  also be expected to enhance any FI hybrid resistance that  RCS may induce. 
The complex effects of the  I  region on responsiveness of T  cells to RCS,  and on 
tumor growth,  are of great  interest.  Previous studies  that  show  I-region effects on 
tumor growth  in  F1  hybrids  (41)  have suggested  the  presence of immune response 
genes  in  this  region  that  regulate cytotoxic or antibody responses against  a  tumor- 
associated viral antigen.  Although  studies are in progress to examine the possibility 
that Fa hybrids give better immune response to RCS than do SJL/J mice, there are 
other mechanisms that might account  for the I-region effects. Previous studies  have 
indicated that either an antigen closely connected with I-A, or I-A itself, induces the 
proliferation  of syngeneic T  cells  to  RCS,  because  the  presence  of anti-I-A  in  the 
medium specifically inhibits this response (2). The decreasing effect on the proliferative 
responsiveness in F1 hybrids of I-A in apparently all haplotypes other than I-A  S, but 
strongest  in  I-A  k  and  weakest  in  LA  b,  might  indicate  that  a  similarity  between 
responder and stimulating cells in  the  I-A region  facilitates  this response.  Homozy- 
gosity in  the I-A region could  thus  increase responsiveness to T-RCS.  However, the 
most striking effect observed is that of the  I-E/C region that  appears to correspond 
entirely to the ability of the haplotype to express a product in this region (42). Thus, 
a  strongly negative effect on  proliferation  is seen  from I-E/C  d and  I-E/C  k, but  not 
from I-E/C  b or I-E/C  f. It may be argued that the interaction gene product known to 
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the molecular form of I-A (44), are sufficiently changing the responder cell surface of 
the F1 hybrid to make responsiveness impossible.  In addition, any negative effect of 
H-2D  a, and possibly also of H-2  k, on the proliferative responsiveness to y-RCS could 
perhaps he a result of a regulatory effect of Hh genes on the expression of genes in the 
I region. 
h  should  be  realized  that  a  loss  of responsiveness of T  cells  to  y-RCS could be 
either on the basis of a  progressive loss of similarity of responder to stimulator cell 
(assuming  a  syngeneic interaction  between  T  and  B  cells  by a  lock- and  key-type 
mechanism)  or,  in  contrast,  on  the  basis  of an  increase  in  similarity.  The  latter 
interpretation  postulates expression of a  normally repressed  I-E/C  s gene product on 
RCS cells that is absent from normal SJL/J cells. Thus, the abnormally high response 
to y-RCS of some F1 mice as compared with the normal syngeneic mixed lymphocyte 
reaction, which T cells of all F1 mice show to both parental and to F1 non-T-stimulator 
cells  alike  (Table V), would be explained on the basis of an allorecognition by cells 
from  those  F1  mice  not  expressing  an  interaction  product  in  the  I-E/C  region. 
However,  if  heterozygosity  in  I-E/C  ~ ×  (k or d)  would  lead  to  expression  of  this 
postulated I-E/C  s product, or else,  if the I-E/C  k or I-E/C  a would be very similar (or 
identical)  to this I-E/C  ~ product, then the T  cells of F1 hybrids of SJL (H-2  ~) by H-2  k 
or H-2  d would no longer recognize RCS as foreign and respond, as they do, to RCS 
and  normal  SJL/J  non-T cells  to  the same  degree.  It  should  be  noted  that  recent 
studies  by others  (45,  46)  indicate  the expression  of foreign H-2 antigens on tumor 
cells,  and that Roman and Bonavida (47) have described the expression of H-2d-like 
antigens  on  in  vitro  lines  of RCS  that,  however, have some changed properties  as 
compared with the in vivo lines.  In our laboratory, no direct evidence for the presence 
of alien H-2 antigens on in vivo transplantable RCS has been obtained so far. 
The  correlation  between  growth  and  proliferative  response still  deserves  further 
comment. Analysis of the accessory cell requirements  for the RCS growth in SjL/j 
mice  in  vivo has  led  to  the  suggestion that  both T  and  M  cells  are  needed  for its 
growth (5). Adult thymectomized, irradiated and bone marrow reconstituted as well 
as  nude  mice of SJL/J  genotype (48)  also  show  less RCS  growth  than  do  normal 
SJL/J  mice  (~50%  reduction).  Thus,  the  proliferative  response  may itself in  some 
way facilitate  RCS  growth in  vivo, possibly by activation  (3)  or  via  production of 
growth-promoting soluble mediators. 
Summary 
Growth of three  transplantable  reticulum  cell  sarcomas  (RCS)  was studied  in  a 
variety of F1 hybrids of SJL/J mice by determination of lymph node (LN) and spleen: 
body weight ratios  7 and  14 d  after intravenous injection of RCS cells.  Comparison 
of BIO.S X SJL and A.SW X SJL with SJL/J showed a negative effect of both the A 
and the BIO non-H-2 genes, particularly on growth in LN. F1 hybrid resistance was 
noted with F1 hybrids that carried H-2D  d and was much more evident with F1 hybrids 
fi-om BIO- than from A-background mice. This resistance was less marked at  14 than 
at  7 d and was partially overcome by injection of higher tumor doses.  Changing the 
I  region  in  the  F1  parent  from  H-28  to  H-2  b or H-2  f had  no effect  on growth, but 
changing to  H-2  k or H-2  d virtually abolished  the  ability to support  tumor growth. 
This  effect  appeared  partially  as  a  result  of the  I-E/C and  partially  of the  I-A(B) 
region and was not overcome by higher tumor dose or longer intervals after injection. KATZ, LERMAN, PONZIO, SHREFFLER, AND  TItORBECKE  359 
There  also appeared to  be a  negative influence on  growth  of H-2K  k,  but  this was 
difficult to differentiate from the I-A  k effect with the available strains. 
The  known  proliferative  responsiveness  that  SJL/J  Lyt-1  T  cells  exhibit  to  Ia 
determinants on ,/-irradiated RCS cells in vitro was also compared with that of cells 
from various F1 hybrids. Responsiveness of F1 LN cells was expressed as a  percentage 
of the response in SJL/J  LN cells to the same RCS cells, measured as [aH]thymidine 
incorporation.  There  was  a  striking degree  of correlation  between  proliferative re- 
sponsiveness of F1 LN cells to RCS  and the ability of the F1 mice to support  tumor 
growth. This correlation was especially clear with respect to the negative influences of 
non-H-2 genes, and of H-2 loci in the I  region, particularly of I-A  k or -a and of I-E/ 
C k  or  -a,  but  there  also  appeared  to  be  a  (smaller)  negative  effect  of I-A  b  or  -f 
Negative  influence  of H-2D  a  on  growth,  however,  was  not  reflected  in  a  similarly 
large effect on  the proliferative response.  Additional findings showed  that  LN cells 
from all F1 hybrids exhibited equivalent syngeneic mixed lymphocyte responses in the 
presence of polyethylene glycol to mitomycin-treated spleen cells from both the SJL/ 
J and the other parent. The extra high response of F1 cells to RCS cells, as compared 
with SJL spleen cells, however, was always absent when  I k or -d was contributed by 
one of the F1 parents. 
The results suggest a  promoting effect of the proliferative response on RCS growth 
in vivo and, furthermore, an interesting effect of I-A and I-E/C genes, possibly via an 
interaction product, on the ability of LN cells to be stimulated by Ia determinants on 
RCS cells. 
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